Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H23NO2 |
| Molecular Weight | 261.3593 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)O[C@@]1(CCN(C)C[C@@H]1C)C2=CC=CC=C2
InChI
InChIKey=UVAZQQHAVMNMHE-XJKSGUPXSA-N
InChI=1S/C16H23NO2/c1-4-15(18)19-16(14-8-6-5-7-9-14)10-11-17(3)12-13(16)2/h5-9,13H,4,10-12H2,1-3H3/t13-,16+/m0/s1
| Molecular Formula | C16H23NO2 |
| Molecular Weight | 261.3593 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
50.08 μg × min/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7358866 |
35 mg/kg bw single, intravenous dose: 35 mg/kg bw route of administration: Intravenous experiment type: SINGLE co-administered: |
ALPHAPRODINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
4.6 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7358866 |
35 mg/kg bw single, intravenous dose: 35 mg/kg bw route of administration: Intravenous experiment type: SINGLE co-administered: |
ALPHAPRODINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Three auxiliary medications in obstetrics. 1955]. | 2010-11 |
|
| Structure determination of neoefrapeptins A to N: peptides with insecticidal activity produced by the fungus Geotrichum candidum. | 2006-05 |
|
| Local anesthesia and narcotic drug interaction in pediatric dentistry. | 1988-01-01 |
|
| Ketamine-pancuronium-narcotic technic for cardiovascular surgery in infants--a comparative study. | 1975-11-01 |
|
| The combined use of alphaprodine (nisentil) hydrochloride and levallorphan (lorfan) tartrate for analgesia in obstetrics. | 1957-08 |
|
| Use of Nisentil hydrochloride as an analgesic agent during cystoscopic procedures. | 1954-04 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:43 GMT 2025
by
admin
on
Mon Mar 31 17:45:43 GMT 2025
|
| Record UNII |
001O2254AC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9010
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C83528
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
CHEMBL1623765
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
100000087470
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
Prodine
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
001O2254AC
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
77-20-3
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
DB13160
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
1063
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
3283
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
132
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
594
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB05366MIG
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
120738
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
m1576
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | Merck Index | ||
|
D000522
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
201-011-5
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY | |||
|
DTXSID4022575
Created by
admin on Mon Mar 31 17:45:43 GMT 2025 , Edited by admin on Mon Mar 31 17:45:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |